ANIX vs TECH · rev $210.0K vs P/E 65, rev $1.22B
Anixa Biosciences Inc (ANIX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Anixa Biosciences Inc (ANIX) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ANIX revenue for 2024-10-31 was $210.0K. Net income was -$12.7M. Revenue was up 0.0% from 2023-10-31 to 2024-10-31. ANIX currently screens at market cap $101.1M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ANIX currently screens at market cap $101.1M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ANIX and TECH stock pages for the full models.
Not investment advice.